Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries

BACKGROUND: Benzodiazepines (BZD) and benzodiazepine receptor agonists (zolpidem, zaleplon, zopiclone, altogether Z-drugs) are most commonly prescribed for the treatment of insomnia. However, long-term use of BZD/Z-drugs is associated with major adverse events including, but not limited to, falls an...

Descripción completa

Detalles Bibliográficos
Autores principales: Clay, Emilie, Falissard, Bruno, Moore, Nicholas, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610030/
https://www.ncbi.nlm.nih.gov/pubmed/23114457
http://dx.doi.org/10.1007/s00228-012-1424-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610030/
https://www.ncbi.nlm.nih.gov/pubmed/23114457
http://dx.doi.org/10.1007/s00228-012-1424-1

Ejemplares similares